Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25781207 | 0.96 | CYP4F2 (0.37) | CYP4F2CYP4A11S1PR1S1PR5 | |
| SCHEMBL25772135 | 0.89 | CYP4F2 (0.37) | CYP4F2CYP4A11L3MBTL1S1PR5NPC1 | |
| SCHEMBL25773868 | 0.88 | CCR5 (0.35) | CYP4F2CYP4A11S1PR1S1PR5 | |
| SCHEMBL25772187 | 0.88 | FNTA (0.35) | HRH3 | |
| SCHEMBL25781205 | 0.86 | CYP4F2 (0.39) | CYP4F2CYP4A11S1PR1S1PR5ALDH1A1 | |
| SCHEMBL25772697 | 0.85 | KMT2A (0.34) | — | |
| SCHEMBL25772194 | 0.84 | RORC (0.38) | CYP4F2CYP4A11S1PR1S1PR5LMNA | |
| SCHEMBL25771786 | 0.79 | OXER1 (0.38) | CYP4F2CYP4A11S1PR1S1PR5 | |
| SCHEMBL25781417 | 0.79 | OXER1 (0.43) | — | |
| SCHEMBL25775002 | 0.78 | CYP4F2 (0.39) | CYP4F2CYP4A11S1PR1S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115203-A1 | OXER1 ANTAGONISTS AND USES THEREOF | FAIRHAVEN PHARMACEUTICALS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |